Beck took up his position at 4d in March, having previously held similar roles at three publicly-listed biotech groups during a thirty-year career. “We grieve this loss and will carry his legacy forward in this next chapter of 4D pharma continued growth and progress.”ĤD pharma will continue to be actively led by its current management team and board of directors and succession planning is underway, said the statement. 242 4D pharma PLC ( AIM:DDDD, NASDAQ:LBPS, FRA:4DY) (LON:DDDD, NASDAQ LBPS) has announced the death of John Beck, the group’s chief financial officer. “John’s 30 years of experience in the financial and biopharmaceutical industries were invaluable to us in his role as Chief Financial Officer, and his vision for the future of 4D pharma was already well on its way to being realized,” he added. The entire 4D pharma community mourns this loss and, on behalf of our board of directors and employees, we extend our sincerest condolences to his family,” said Duncan Peyton, chief executive. “We are deeply saddened by John’s passing. Investors: ARCH Venture Partners, the Flippen Group, GPG Ventures, 4D. We are deeply saddened by John’s passing. 4D pharma PLC ( AIM:DDDD, NASDAQ:LBPS, FRA:4DY) (LON:DDDD, NASDAQ LBPS) has announced the death of John Beck, the group’s chief financial officer.īeck took up his position at 4d in March, having previously held similar roles at three publicly-listed biotech groups during a thirty-year career. said John Beck, vice president Business Solutions Portfolio for Allscripts. 136 4D pharma PLC ( AIM:DDDD, NASDAQ:LBPS, FRA:4DY) (LON:DDDD, NASDAQ LBPS) has announced the death of John Beck, the group’s chief financial officer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |